Commerce · Regulated Category · UX Writing · Meta.com Store
A regulated product in a store built for everyone else
Prescription AI glasses launched as Meta's first regulated product on Meta.com. The content had to be present across every surface where users discover, decide and buy, without overwhelming the people who don't need a prescription. Rx attach climbed from 2% to 14% in one quarter, 40% above goal.
Prescription AI glasses were Meta's first regulated product on Meta.com, a store mostly built for shoppers who don't need a prescription. The product had to live inside that store without taking it over, and the content had to satisfy four constraints simultaneously.
Rx had to be present, legible and proportional on every surface where users discover, decide and buy. That meant the homepage, category pages, compare pages, Shop All, every Rx-eligible PDP, the configurator, checkout and the post-purchase confirmation, without making the whole store feel like a regulated experience for the people who didn't need one.
The trap on either side was obvious once you named it. Treat Rx as its own product line and the store splits in two. Treat it as an afterthought and attach rate collapses.
Eight-plus surfaces, owned end-to-end through the launch and the iteration that followed.
A regulated product touching that many surfaces couldn't be hand-crafted page by page. It needed a content pattern other people could pick up, including content designers, PMs and even the legal partners reviewing the work, without rebuilding the trust layer every time.
Show up where Rx serves the user. Recede where it would distract.
On Rx-eligible PDPs, prescription options were prominent. On non-Rx PDPs, they were absent. Discovery surfaces let users opt in without making the whole store about prescriptions.
Required disclosures should feel like helpful guidance, not legal cover.
Compliance language got rewritten in plain terms and positioned where it informed rather than blocked. The non-blocking disclosure pattern I developed for Business chats carried directly into Rx.
Treat compliance as a content problem, not a legal one.
Legal partners reviewed for accuracy. Content design owned what the user actually read and when they read it. Those are different jobs, and conflating them is how regulated flows get rigid.
The principles travelled with the content. New surfaces and new regulated products could pick them up without rebuilding the trust layer each time.
The Rx selection screen was where the principles met the user most directly. It was also where the regression was sharpest: a step that consistently leaked buyers who'd gotten this far into the flow.
Three changes turned it from a drop-off into a conversion lever, each tied to one of the principles above.
Rewrote the descriptions
"Single vision" and "Progressive" are clinical. I rewrote them so users could self-identify: "Helps you see clearly for one distance, like for reading or driving."
Moved the disclosure out of the path
I borrowed the non-blocking disclosure pattern from my Business chats work. Privacy stayed visible. Continue stopped being gated by it.
Added a contextual helper
A hint about ADD value surfaced for users with progressive prescriptions, at the exact moment they were most likely to stop and second-guess.
The same principles held everywhere else on Meta.com. The screen was the proof — but the pattern was the point.
The pattern was built to extend. The same content foundation that held for prescription eyewear is the one future regulated products on Meta.com — health, finance, identity — can pick up without starting from zero.
Took Meta's first regulated product from a 2% attach rate to 14% in a single quarter, 40% past the year's goal. Integrated Rx across 8+ commerce surfaces without disrupting the non-Rx purchase path. Unlocked a net-new third-party retail channel at Best Buy and established the content foundation for future regulated categories on Meta.com.